Author

Andrea Mohr

University of EssexORCID 0000-0002-4295-0341Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Greg Nicholas BrookeiD· 1 shared Natalia KrajewskaiD· 1 shared P BlairiD· 1 shared Pierre Philippe LaissueiD· 1 shared Ralf Michael ZwackaiD· 1 shared Serap GokceniD· 1 shared Stuart A. RushworthiD· 1 shared Tianyuan ChuiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Greg Nicholas BrookeORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

MSC-delivered High-Affinity Variants of soluble PD1 lead to tumour regression

Serap Gokcen, Tianyuan Chu, P Blair, Natalia Krajewska, Greg Nicholas Brooke, Stuart A. Rushworth, Pierre Philippe Laissue, Ralf Michael Zwacka, Andrea Mohr

This paper develops a cell-based immune checkpoint therapy using MSCs to deliver a high-affinity sPD1 variant, showing anti-tumour activity in a mouse model.

Cytotherapy · Jun 11, 2026Peer-reviewedCancer Biology